Henao-Guerrero Natalia, Ricco-Pereira Carolina H, Paranjape Vaidehi V
Department of Small Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA 24061, USA.
Department of Veterinary Clinical Sciences, The Ohio State University-College of Veterinary Medicine, Columbus, OH 43210, USA.
Animals (Basel). 2023 Aug 19;13(16):2674. doi: 10.3390/ani13162674.
Isoflurane is a commonly used inhalation anesthetic in species undergoing veterinary care that induces hypotension, impacting organ perfusion, making it imperative to minimize its occurrence or identify effective strategies for treating it. This study evaluated and compared the hemodynamic effects of DOB, NEP, VAS, and HES in twelve isoflurane-anesthetized Beagle dogs. The order of the first three treatments was randomized. HES was administered last. Data were collected before treatments (baseline) and after 10 min of a sustained MAP of <45 mmHg induced by a high end-tidal isoflurane concentration (T0). Once treatment was initiated and the target MAP was achieved (65 to 80 mmHg) or the maximum dose reached, data were collected after 15 min of stabilization (T1) and 15 min after (T2). A 15 min washout period with a MAP of ≥65 mmHg was allowed between treatments. The intravenous dosage regimens started and were increased by 50% every five minutes until the target MAP or maximum dose was reached. The dosages were as follows: DOB, 5-15 μg/kg/min; NEP, 0.1-2 μg/kg/min; VAS, 0.5-5 mU/kg/min; and HET, 6% 1-20 mL/kg/min. DOB improved CO, DO, and VO, but reduced SVR. VAS elevated SVR, but decreased CO, DO, and VO. HES minimally changed BP and mildly augmented CO, DO, and VO. These treatments failed to reach the target MAP. NEP increased the arterial BP, CO, MPAP, and PAWP, but reduced HR. Norepinephrine infusion at 0.44 ± 0.19 μg/kg/min was the most efficient therapy for correcting isoflurane-induced hypotension.
异氟烷是兽医护理中常用的吸入性麻醉剂,可导致低血压,影响器官灌注,因此必须尽量减少其发生或确定有效的治疗策略。本研究评估并比较了多巴酚丁胺(DOB)、去甲肾上腺素(NEP)、血管加压素(VAS)和羟乙基淀粉(HES)对12只异氟烷麻醉的比格犬的血流动力学影响。前三种治疗的顺序是随机的。HES最后给药。在治疗前(基线)以及由高呼气末异氟烷浓度诱导的平均动脉压(MAP)持续<45 mmHg 10分钟后(T0)收集数据。一旦开始治疗并达到目标MAP(65至80 mmHg)或达到最大剂量,在稳定15分钟后(T1)和之后15分钟(T2)收集数据。治疗之间允许有15分钟的洗脱期,MAP≥65 mmHg。静脉给药方案开始时每五分钟增加50%,直至达到目标MAP或最大剂量。剂量如下:DOB,5 - 15 μg/kg/分钟;NEP,0.1 - 2 μg/kg/分钟;VAS,0.5 - 5 mU/kg/分钟;HES,6% 1 - 20 mL/kg/分钟。DOB改善了心输出量(CO)、氧输送(DO)和氧消耗(VO),但降低了体循环血管阻力(SVR)。VAS升高了SVR,但降低了CO、DO和VO。HES对血压影响最小,轻度增加了CO、DO和VO。这些治疗均未达到目标MAP。NEP增加了动脉血压、CO、平均肺动脉压(MPAP)和肺动脉楔压(PAWP),但降低了心率。以0.44±0.19 μg/kg/分钟的速度输注去甲肾上腺素是纠正异氟烷诱导的低血压最有效的治疗方法。